Abstract
Over the past decade, drug-eluting stents (DES) have greatly transformed the field of interventional cardiology. Generally, three components are included in a DES system: a metal stent platform, a drug carrier or so called ‘stent coating’ and a drug. As such, stent coating plays an important role in the performance of DES. This article will review the evolution of stent coatings and their role in the development of restenosis and thrombosis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have